• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Glial fibrillary acidic protein (GFAP)

ACP01346

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP01346 Target Namegfap
FormLiquid or Lyophilized powderExpression SystemE.coli
Expression Range1-432aaMol Weight54.0 kDa
Protein LengthFull lengthPurityGreater than 90% as determined by SDS-PAGE.
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP14136
Background Information
  • Uniprot Id

    P14136

  • Target Species

    Human

  • Target Name

    GFAP

  • Target Full Name

    Glial fibrillary acidic protein

  • Target Function

    GFAP, a class-III intermediate filament, is a cell-specific marker that, during the development of the central nervous system, distinguishes astrocytes from other glial cells.

  • Target Involvement

    Alexander disease (ALXDRD)

  • Target Subcellular Location

    Cytoplasm.

  • Target Protein Families

    Intermediate filament family

  • Target Tissue Specificity

    Expressed in cells lacking fibronectin.

  • Target Research Area

    Neuroscience

  • Target Synonyms

    ALXDRD; GFAP

  • Target Background

    This gene encodes one of the major intermediate filament proteins of mature astrocytes. It is used as a marker to distinguish astrocytes from other glial cells during development. Mutations in this gene cause Alexander disease, a rare disorder of astrocytes in the central nervous system. Alternative splicing results in multiple transcript variants encoding distinct isoforms.

Inquire Recombinant Human Glial fibrillary acidic protein (GFAP) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification